Featured Research

from universities, journals, and other organizations

Malaria vaccine development paves way for protective therapy

Date:
February 18, 2014
Source:
University of Edinburgh
Summary:
Scientists have made a significant contribution towards the development of a vaccine to prevent malaria. Until now, developing malaria vaccines has been challenging. A vaccine must incorporate key proteins from the malaria parasites, which will trigger production of antibodies by the immune system. These proteins have a complex, intricate structure that is hard to reproduce. Scientists have now found a novel way to produce proteins that could lead to malaria vaccines being easy and cheap to manufacture. They have grown them inside a tiny single-celled aquatic creature, whose biological make-up is similar to that of the malaria parasite. The organism, and the protein, can multiply quickly in the lab.

Scientists have made a significant contribution towards the development of a vaccine to prevent malaria. Researchers have tested a preliminary form of a vaccine against the disease, which is spread by the bite of the mosquito and kills more than 600,000 people each year.

Until now, developing malaria vaccines has been challenging. A vaccine must incorporate key proteins from the malaria parasites, which will trigger production of antibodies by the immune system. These proteins have a complex, intricate structure that is hard to reproduce.

Scientists at the University of Edinburgh have now found a novel way to produce proteins that could lead to malaria vaccines being easy and cheap to manufacture. They have grown them inside a tiny single-celled aquatic creature, whose biological make-up is similar to that of the malaria parasite. The organism, and the protein, can multiply quickly in the lab.

In tests in mice, a vaccine developed using human malaria parasite proteins -- known as MSP-1-BBM -- enabled the immune system to produce antibodies in the bloodstream. These antibodies were shown to respond to the human malaria parasite, indicating that the vaccine would be likely to trigger an immune reaction if it were used in people.

Researchers now hope to develop the vaccine for further testing, with the aim of producing a therapy that will be effective in humans. Scientists say there is a pressing need for new treatments, as many forms of the disease are becoming resistant to existing drugs. Children and pregnant women in sub-Saharan Africa are particularly at risk.

The study, carried out in collaboration with the German company Cilia AG and published in the journal PLoS One, was funded by the European Union.

Dr. David Cavanagh, of the University of Edinburgh's School of Biological Sciences, who led the study, said: "There is a desperate need for an effective vaccine, which can be made easily in large quantities, to protect against this devastating disease. Our findings meet this challenge and, with more work, could lead to a vaccine to help those most at risk."


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Journal Reference:

  1. Graeme J. M. Cowan, Ulrike Bockau, Janna Eleni-Muus, Ingo Aldag, Kay Samuel, Alison M. Creasey, Marcus W. W. Hartmann, David R. Cavanagh. A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila. PLoS ONE, 2014; 9 (1): e87198 DOI: 10.1371/journal.pone.0087198

Cite This Page:

University of Edinburgh. "Malaria vaccine development paves way for protective therapy." ScienceDaily. ScienceDaily, 18 February 2014. <www.sciencedaily.com/releases/2014/02/140218101300.htm>.
University of Edinburgh. (2014, February 18). Malaria vaccine development paves way for protective therapy. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2014/02/140218101300.htm
University of Edinburgh. "Malaria vaccine development paves way for protective therapy." ScienceDaily. www.sciencedaily.com/releases/2014/02/140218101300.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins